Hi
@Poli I fully understand your viewpoint, and I'd love to see all types of advanced monitoring available on prescription, but as Jamie Reed knows, a petition to get the Libre or any other form of CGM available on the NHS, wherever in the UK that is is not how the system works and will not make the process that is currently being gone through any faster. In many cases it can hinder the process.
Why?
The NHS has to assess products like the Libre based on clinical evidence. It is, ultimately, an outcomes based system, and needs to determine a "value" approach. Historically, CGM has not been able to provide evidence of the value of the product versus the cost, because, as you'll understand, the rate at which sensors are replaced according to the manufacturer has always been what cost has had to be based on, and the NICE models have set a limit above which they consider the costs to be unsustainable. Sadly, we are not the only people with long term conditions that cost a lot of money. Let's remember that although Type 2 diabetics would benefit if they were taught to use test strips properly, they are supplied none and it is considered unnecessary. I'd say that they have a far greater need of intervention, yet we as a population are demanding superior monitoring because it is there.
My understanding is that the clinical factors that trials have to demonstrate will be in line with what the NICE guidelines state, namely that by the introduction of a product that reduces fingerpricks, Hba1C will have to be shown to be non-inferior (which I think the studies they've published already show) and that there are other benefits, such as reduced hypoglycaemia (which is a good analogue for glycaemic variability).
Abbott believe that they have already pulled together enough evidence to demonstrate the criteria that the NHS needs to prescribe this product in particular and have entered into the appropriate process with the NHS BSA to get it made available on prescription. This will include/need a NICE technology assessment and recommendation.
Note that this has taken place without any involvement of either the UK or Scottish Parliaments, and without the use of any petitions. The next step in the process is to get CCGs in the UK to fund the prescriptions.
But let's take the step to the CCGs, where the prescribing budget lies. Our local CCG, like many, is trying to drop their prescribing budget by 5% to 8%. All CCGs has a whole have been given a target to reduce spend on prescriptions by £150mn this year.
So let's look at this range of groups involved in handling the money and dealing with new technology on the NHS. And let's take a proper strategy into dealing with it. So far we've had a variety of petitions demanding things of parliaments. How about we take a different approach. How about we do something collectively and structured? As a UK population?
Here's my proposal. Everyone who wants this stuff on the NHS needs to participate in a patient led capture of data that provides evidence of the benefits they see from it. We need to get together at the CCG level and demonstrate the difference that introducing these technologies has on our Hba1C levels and our glycaemic variability. I'll volunteer to set up the data capture if you like?
Real evidence from the people who it counts for. Once you start to capture the data, then you can present it to the bodies, and start to talk to the media about what's being done. If we want to beat the system, we need to do it in a way the system isn't yet ready for. And boy is it ready for petitions that will take you nowhere.